Delivery Order SPE2DB20D3103-SPE2DB23FN1E4
Award Date
4/18/23
Potential Completion Date
4/19/23
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,387.26 firm fixed-price delivery order is for the supply of Phenobarbital 65 mg/ml vials. The contract has a period of performance through November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $2,885.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Phenobarbital 130 mg/ml vials, a medication commonly used for the treatment of seizure disorders. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,065.20 firm-fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL solution, a critical medication, to support federal healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This federal contract award, valued at $2,457.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PHENOBARBITAL 65 MG/ML VIALML. The award has an ultimate completion date of November 6, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $3,005.42 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has a period of performance through February 20, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999...
This federal contract award, valued at $5,892.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of January 7, 2025, is for the delivery of Phenobarbital 130 mg/ml vials. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,914.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567583073 - PHENOBARBITAL 130 MG/ML VIALML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a period of performance through March 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,776.56 firm fixed-price delivery order covers the supply of 130 mg/mL vials of the drug Phenobarbital. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,855.42 firm fixed-price delivery order is for the supply of Phenobarbital 65 mg/mL vials, a medical product used in various healthcare settings. The contract has an ultimate completion date of January 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...